Drug-supplement interactions on intestinal absorption and its genetic individual variations
- Conditions
- healthy volunteer
- Registration Number
- JPRN-UMIN000004687
- Lead Sponsor
- APDD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 16
Not provided
the investigors must ensure that all subjects being considerd meet the following exclusion criteria or conditions 1) blood disorder and impairment of liver and kidney function 2) history of asthma 3) porphyria patient 4) deficiency of glucose-6-phosphdehydrogenase 5) impairment of liver or kidney functions 6) grapefruit, orange and apple juice intake within 7 days prior to test drug administration 7) regular use of St. John's Wort 8) recent (past 4 months) participation in other clinical trial using new chemical entity 9) donation of 400mL or more of blood within 3 months prior to participation, donation of 200mL or more of blood within 1 month prior to participation, or donation of component blood within 2 weeks prior to participation 10) positive serologic reaction of syphilis, positive result of HIV test, HBsAg and HCVAb 11) history of multiple and recurring allergies to medicines or food 12) history of drug or alcohol abuse and capable to refrain from alcohol for the designated term 13) the investigator determines this trial participation inadequate by the information at the screening visit 14) vulnerable to alcohol or incapable to intake alcohol 15) the investigator determines this trial participation inadequate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PK parameters of salazosulfapyridine and rosuvastatin plasma concentration
- Secondary Outcome Measures
Name Time Method